Principal Investigator

Larissa Mooney, MD

Department of Psychiatry and Biobehavioral Sciences - UCLA

  • 2 trials
  • 1 compound

Therapeutic focus

  • Opioid-Related Disorders
  • Substance-Related Disorders
  • Narcotic-Related Disorders
  • Cannabis Use Disorder
  • Marijuana Abuse

All trials (2)

NCTPhaseStatusCompoundSponsor
NCT06023459Phase 3Completed—
NCT05322941Phase 2CompletedAEF0117 (lixosicone)

Compounds studied

Trial sites (18)

  • Phoenix, Arizona, United States
  • Gibson City, Illinois, United States
  • Charleston, South Carolina, United States
  • New Martinsville, West Virginia, United States
  • Miami Lakes, Florida, United States
  • Portland, Oregon, United States
  • Garberville, California, United States
  • Belfast, Maine, United States
  • El Dorado, Arkansas, United States
  • San Antonio, Texas, United States
  • Draper, Utah, United States
  • Los Angeles, California, United States
  • Garden Grove, California, United States
  • Scappoose, Oregon, United States
  • Lauderhill, Florida, United States
  • New York, New York, United States
  • New Haven, Connecticut, United States
  • Colville, Washington, United States

Investigator and site data mirrored fromClinicalTrials.gov (public domain).